Imagine a world where technology doesn’t just correct vision—it enhances it beyond what even 'normal' glasses can achieve. That’s the promise of the eSight Go, a groundbreaking device unveiled at CES 2026 that’s changing lives for people with central vision loss. But here’s where it gets controversial: while it’s a game-changer for many, its $4,950 price tag and lack of insurance coverage leave it out of reach for countless others. Is this innovation truly inclusive, or does it highlight the gaps in accessibility? Let’s dive in.
At CES, I had the chance to meet Liz Baker, a woman living with macular degeneration who uses the eSight Go daily. Her story is nothing short of inspiring. With these smart glasses, she can read ingredient labels, see her daughter’s freckles, and shop independently—tasks that were once impossible. And this is the part most people miss: the eSight Go doesn’t just magnify; it leverages peripheral vision to fill in the central 'blind spot' caused by conditions like macular degeneration or diabetic retinopathy. The result? Users report up to seven lines of improvement on vision charts—a life-altering leap.
But how does it work? The eSight Go is a headset with small screens in front of your eyes, similar to a VR device but compact enough to wear comfortably. A battery pack rests around the back of your neck, balancing the weight and making it surprisingly wearable. The real magic lies in its features: zoom in or out with buttons or a remote, adjust contrast, or freeze-frame to read text as if it’s a giant billboard. For someone like Liz, this means no more mistaking shampoo for conditioner at the store.
Here’s the catch: at $4,950, the eSight Go is a significant investment, and most insurance plans won’t cover it. While the Department of Veterans Affairs and some state vocational programs offer assistance, many users are left to foot the bill themselves. Is this a fair trade-off for life-changing technology, or does it underscore the inequities in healthcare access?
One feature that stands out is the built-in support system. New users gain access to a ‘coach’—someone with vision loss who’s already mastered the device. This peer-to-peer guidance is invaluable, but it raises another question: should such innovative tools come with equally innovative support models?
Battery life is another practical consideration. With about four hours of use per charge, Liz admits she doesn’t wear the glasses continuously. Instead, she keeps them around her neck in sleep mode, conserving power for when she needs them most. It’s a workaround, but it works—though it begs the question: could future iterations offer longer-lasting batteries?
Critics might point out that max zoom can sometimes pixelate images, but Roland Mattern, the director of sales, notes that most users don’t need extreme magnification. Even so, the debate remains: should perfection be the standard for assistive technology, or is progress enough?
What do you think? Is the eSight Go a revolutionary step forward, or does its cost limit its impact? Share your thoughts in the comments—let’s spark a conversation about accessibility, innovation, and equity in tech.
